Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Chari RVJ, Miller ML, Widdison WC. Antibody–drug conjugates: an emerging concept in cancer therapy. Angew Chem Int Ed. 2014;53(15):3796–827. https://doi.org/10.1002/anie.201307628.
2. Alley SC, Zhang X, Okeley NM, Anderson M, Law C-L, Senter PD, et al. The pharmacologic basis for antibody-auristatin conjugate activity. J Pharmacol Exp Ther. 2009;330(3):932–8. https://doi.org/10.1124/jpet.109.155549.
3. Sanderson RJ, Hering MA, James SF, Sun MMC, Doronina SO, Siadak AW, et al. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate. Clin Cancer Res. 2005;11:843–52.
4. Hamblett KJ, Senter PD, Chace DF, Sun MMC, Lenox J, Cerveny CG, et al. Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin Cancer Res. 2004;10(20):7063–70. https://doi.org/10.1158/1078-0432.ccr-04-0789.
5. Bakhtiar R. Antibody drug conjugates. Biotechnol Lett. 2016;38(10):1655–64. https://doi.org/10.1007/s10529-016-2160-x.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献